AU2002214150A1 - Canine and feline tumour-associated antigen 5t4 - Google Patents

Canine and feline tumour-associated antigen 5t4

Info

Publication number
AU2002214150A1
AU2002214150A1 AU2002214150A AU1415002A AU2002214150A1 AU 2002214150 A1 AU2002214150 A1 AU 2002214150A1 AU 2002214150 A AU2002214150 A AU 2002214150A AU 1415002 A AU1415002 A AU 1415002A AU 2002214150 A1 AU2002214150 A1 AU 2002214150A1
Authority
AU
Australia
Prior art keywords
feline
canine
tumour
associated antigen
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214150A
Inventor
Miles Carroll
Noel Drury
Kevin Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2000/004317 external-priority patent/WO2001036486A2/en
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Publication of AU2002214150A1 publication Critical patent/AU2002214150A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002214150A 2000-11-13 2001-11-13 Canine and feline tumour-associated antigen 5t4 Abandoned AU2002214150A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU12900/01 2000-11-13
PCT/GB2000/004317 WO2001036486A2 (en) 1999-11-18 2000-11-13 Scfv antibodies against disease associated molecules
PCT/GB2001/005004 WO2002038612A2 (en) 2000-11-13 2001-11-13 Canine and feline tumour-associated antigen 5t4

Publications (1)

Publication Number Publication Date
AU2002214150A1 true AU2002214150A1 (en) 2002-05-21

Family

ID=9886275

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214150A Abandoned AU2002214150A1 (en) 2000-11-13 2001-11-13 Canine and feline tumour-associated antigen 5t4

Country Status (4)

Country Link
US (3) US7402666B2 (en)
EP (1) EP1347994A2 (en)
AU (1) AU2002214150A1 (en)
WO (1) WO2002038612A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7148035B1 (en) * 1998-11-18 2006-12-12 Oxford Biomedica (Uk) Limited Polypeptide
GB0203419D0 (en) * 2002-02-13 2002-04-03 Oxford Biomedica Ltd Peptide
US6987270B2 (en) 2003-05-07 2006-01-17 General Electric Company Method to account for event losses due to positron range in positron emission tomography and assay of positron-emitting isotopes
GB0519303D0 (en) * 2005-09-21 2005-11-02 Oxford Biomedica Ltd Chemo-immunotherapy method
GB0520067D0 (en) * 2005-10-01 2005-11-09 Cancer Rec Tech Ltd Treatment of cancer
AU2013216628C1 (en) * 2006-03-10 2016-02-04 Wyeth Llc Anti-5t4 antibodies and uses thereof
US8044178B2 (en) * 2006-03-10 2011-10-25 Wyeth Llc Anti-5T4 antibodies and uses thereof
US8642274B2 (en) * 2008-07-15 2014-02-04 Oxford Biomedica, Inc. Immunotherapeutic method
JP2014533929A (en) 2011-09-23 2014-12-18 アムゲン リサーチ （ミュンヘン） ゲーエムベーハー Bispecific binding molecules for 5T4 and CD3
CN108084265B (en) * 2016-11-23 2021-07-02 复旦大学 Fully human single domain antibody specifically binding to human 5T4 antigen and application thereof
KR102609624B1 (en) 2017-03-15 2023-12-05 옥스포드 바이오메디카(유케이) 리미티드 method
FR3115988A1 (en) 2020-11-06 2022-05-13 Global Bioenergies Make-up composition based on biosourced isododecane and process for its preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403559A1 (en) * 1988-03-04 1990-12-27 Cancer Research Campaign Technology Limited Improvements relating to antigens
ATE293690T1 (en) 1998-11-18 2005-05-15 Oxford Biomedica Ltd USE OF CANCER-ASSOCIATED ANTIGEN 5T4 FOR IMMUNOTHERAPY
AU1290001A (en) 1999-11-18 2001-05-30 Oxford Biomedica (Uk) Limited Antibodies

Also Published As

Publication number Publication date
WO2002038612A3 (en) 2003-05-08
US20040081656A1 (en) 2004-04-29
US7659383B2 (en) 2010-02-09
US20080274542A1 (en) 2008-11-06
WO2002038612A2 (en) 2002-05-16
US20080279854A1 (en) 2008-11-13
US7402666B2 (en) 2008-07-22
EP1347994A2 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
AU2001252458A1 (en) Molecular antigen arrays and vaccines
AU2001272879A1 (en) Secure and reliable document delivery
AU2001268341A1 (en) System for wireless push and pull based services
AU6451901A (en) Efficient scatternet forming
GB0010434D0 (en) Cat flap
AU2001253418A1 (en) Compounds and methods
AU2000267608A1 (en) Catheter package and method
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002211717A1 (en) Stresscopins and their uses
AU2002214150A1 (en) Canine and feline tumour-associated antigen 5t4
AU2001287934A1 (en) Document feeder and method
AU2001283505A1 (en) Package printer and transport assembly
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ342599A0 (en) Conjugates and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPR126500A0 (en) Documents envelope
AU2001266939A1 (en) Biocidal polyamides and methods
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AUPQ872300A0 (en) Compounds and methods
AU2002225749A1 (en) Powered periotome
AU2001259450A1 (en) Cytoskeleton-associated proteins
AU2001257523A1 (en) Bottle and bottle coupler
AU3283500A (en) Tumor-associated antigen
AU2001278951A1 (en) Compounds and methods